An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting products of uncertain source.
Several experts stated the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Removal
Based on TikTok, the service has removed problematic material and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Trading Activities
Investigations also discovered groups with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Information and Pricing
Within these groups, messages show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
